Value based pricing for NHS drugs: an opportunity not to be missed?

被引:147
作者
Claxton, Karl [1 ,2 ]
Lindsay, Andrew Briggs [3 ]
Buxton, Martin J. [4 ]
Culyer, Anthony J. [2 ,5 ]
McCabe, Christopher [6 ]
Walker, Simon [1 ]
Sculpher, Mark J. [1 ]
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England
[5] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] Univ Leeds, Inst Hlth Sci, Leeds, W Yorkshire, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 336卷 / 7638期
基金
英国医学研究理事会;
关键词
D O I
10.1136/bmj.39434.500185.25
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:251 / 254
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 2007, PHARM PRIC REG SCHEM
[2]   Using value of information analysis to prioritise health research - Some lessons from recent UK experience [J].
Claxton, Karl P. ;
Sculpher, Mark J. .
PHARMACOECONOMICS, 2006, 24 (11) :1055-1068
[3]   Parliamentary review asks NICE to do better still - Out goes the arbitrary funding threshold: income NICE "directives" [J].
Collier, Joe .
BRITISH MEDICAL JOURNAL, 2008, 336 (7635) :56-57
[4]   The Pharmaceutical Price Regulation Scheme - Proposals for a new drug pricing mechanism in the NHS are welcomed [J].
Collier, Joe .
BRITISH MEDICAL JOURNAL, 2007, 334 (7591) :435-436
[5]  
Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567
[6]  
*DEP BUS ENT REG R, 2007, INT GOV RESP OFF FAI
[7]  
MARTIN S, 2007, 24 U YORK CTR HLTH E
[8]  
*NIH CLIN EXC, 2008, HC27I STAT OFF NIH C
[9]  
*NIH CLIN EXC, 2007, CLIN PUBL HLTH DIR P